Lumos Diagnostics extended its distribution agreement with Henry Schein Medical to include Belgium.

The partnership will introduce the FebriDx point-of-care test to Belgian healthcare practitioners, offering a rapid diagnostic tool that differentiates viral from bacterial acute respiratory infections within 10 minutes using a fingerstick blood sample.

FebriDx is suitable for primary care, urgent care, emergency departments, paediatrics, and other outpatient settings.

Henry Schein Medical, already distributing FebriDx in the Netherlands, Portugal, Spain, the UK, and the US, expanded into Belgium in 2023, targeting general practitioners and midwives.